ACADIA Pharmaceuticals In... (ACAD)

ACAD trades at $21.8, 9.2% below the near-term max pain of $24 expiring Oct 17, 2025 (12 days). Look for upward drift as max pain acts as a magnet pulling price higher. Max pain is rising across expirations ($7.5-$24), reflecting growing call interest at higher strikes. Key magnetic zone at 24 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ACAD shows an upward trend from 7.5 to 24, suggesting bullish positioning in longer-dated options. The 81% spread signals divergent expectations across timeframes. Levels distributed around 21.8. Strong magnetic level at 24 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.